Anti-CD7 CAR-T

DB23322InvestigationalCell transplant therapies

CD7 CAR-T is a biologic drug. CD7 CAR-T is under investigation in clinical trial NCT07117305 (CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation).

Mechanism: Pharmacologically active on T-cell antigen CD7
Curator reviewed
Also known as: CD7 CAR T · CD7 CAR T cells · CD7 CAR T-cells · CD7 CAR- T · CD7 CAR-T

Resolves to

Targets

P09564CD7

What you can answer from here — as of June 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

38Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anti-CD7 CAR-T, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account